Nuclear β-Catenin then activates the transcription of target genes, including NTSR1 and EGFR. It results (i) a sustained autocrine signaling loop via NTSR1 and (ii) a sustained expression and activation of EGFR and its downstream effectors (such as ERK1/2), thus promoting tumor progression and invasion. The gene discussed is NTSR1; the disease is neoplasm.